Home » Newsletters » BioWorld Asia

BioWorld Asia

April 4, 2001

View Archived Issues

Micromet Raises EUR40M In Fourth Financing Round

Nasdaq Buying Part Of Easdaq In Move That Helps Biotech Firms

Transgene Decides To Refocus, Concentrate On Cancer Programs

Meristem Partners With Goodwin To Gain Foothold In U.S. Market

Alchemia Raises A$15.2M To Expand Research, U.S. Operation

Canada Invests C$21M For Stem Cell Research Initiative

EMEA Sets Out Plans Covering Biotechnology For Next 2 Years

Hybrigenics Launches Map On Protein HIV Interactions

Other News To Note

Oxford Gene, Affymetrix Settle Microarray Patent Litigation

New Group Formed To Assess Drug Competitiveness Issues

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...